AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-90
Results: 1-25/90
MOLECULAR CYTOGENETIC DELINEATION OF 17Q TRANSLOCATION BREAKPOINTS INNEUROBLASTOMA CELL-LINES
Authors: LASTOWSKA M VANROY N BROWN N SPELEMAN F LUNEC J STRACHAN T PEARSON ADJ JACKSON MS
Citation: M. Lastowska et al., MOLECULAR CYTOGENETIC DELINEATION OF 17Q TRANSLOCATION BREAKPOINTS INNEUROBLASTOMA CELL-LINES, Genes, chromosomes & cancer, 23(2), 1998, pp. 116-122
RETINOID-INDUCED DIFFERENTIATION OF NEUROBLASTOMA - COMPARISON BETWEEN LG69, AN RXR-SELECTIVE ANALOG AND 9-CIS RETINOIC ACID
Authors: IRVING H LOVAT PE HEWSON QC MALCOLM AJ PEARSON ADJ REDFERN CPF
Citation: H. Irving et al., RETINOID-INDUCED DIFFERENTIATION OF NEUROBLASTOMA - COMPARISON BETWEEN LG69, AN RXR-SELECTIVE ANALOG AND 9-CIS RETINOIC ACID, European journal of cancer, 34(1), 1998, pp. 111-117
PHARMACOKINETICS AND BLOOD DISTRIBUTION IN PEDIATRIC-PATIENTS OF SPI-77 - CISPLATIN ENCAPSULATED IN STEALTH(R) LIPOSOMES
Authors: BODDY AV GRIFFIN MJ DICK GS LITTLE MA YULE SM WELBANK H PEARSON ADJ ESTLIN EJ
Citation: Av. Boddy et al., PHARMACOKINETICS AND BLOOD DISTRIBUTION IN PEDIATRIC-PATIENTS OF SPI-77 - CISPLATIN ENCAPSULATED IN STEALTH(R) LIPOSOMES, Annals of oncology, 9, 1998, pp. 493-493
DEOXYURIDINE PLASMA-LEVELS DURING THE PHASE-I STUDY OF NOLATREXED IN CHILDREN WITH ADVANCED CANCER
Authors: TAYLOR GA ESTLIN EJ PINKERTON CR GOWING R LASHFORD L MORLAND B LEWIS IJ NEWELL DR BODDY AV JOHNSTON A PEARSON ADJ
Citation: Ga. Taylor et al., DEOXYURIDINE PLASMA-LEVELS DURING THE PHASE-I STUDY OF NOLATREXED IN CHILDREN WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 618-618
ACUTE CHANGES IN URINE PROTEIN EXCRETION MAY PREDICT CHRONIC IFOSFAMIDE NEPHROTOXICITY - A PRELIMINARY OBSERVATION
Authors: MACLEAN FR SKINNER R HALL AG ENGLISH M PEARSON ADJ
Citation: Fr. Maclean et al., ACUTE CHANGES IN URINE PROTEIN EXCRETION MAY PREDICT CHRONIC IFOSFAMIDE NEPHROTOXICITY - A PRELIMINARY OBSERVATION, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 413-416
WHAT CAN WE EXPECT FROM NEUROBLASTOMA SCREENING - CLINICIAN POINT-OF-VIEW
Authors: LADENSTEIN R MATTHAY K BERTHOLD F KOGNER P PEARSON ADJ FRAPPAZ D DEBERNARDI B YAMAMOTO K HARTMANN O
Citation: R. Ladenstein et al., WHAT CAN WE EXPECT FROM NEUROBLASTOMA SCREENING - CLINICIAN POINT-OF-VIEW, Medical and pediatric oncology, 31(5), 1998, pp. 408-418
EXPRESSION OF THE ERBB-NEUREGULIN SIGNALING NETWORK DURING HUMAN CEREBELLAR DEVELOPMENT - IMPLICATIONS FOR THE BIOLOGY OF MEDULLOBLASTOMA
Authors: GILBERTSON RJ CLIFFORD SC MACMEEKIN W WRIGHT C PERRY RH KELLY P PEARSON ADJ LUNEC J
Citation: Rj. Gilbertson et al., EXPRESSION OF THE ERBB-NEUREGULIN SIGNALING NETWORK DURING HUMAN CEREBELLAR DEVELOPMENT - IMPLICATIONS FOR THE BIOLOGY OF MEDULLOBLASTOMA, Cancer research, 58(17), 1998, pp. 3932-3941
CYCLOPHOSPHAMIDE METABOLISM IN CHILDREN WITH FANCONIS-ANEMIA
Authors: YULE SM PRICE L COLE M PEARSON ADJ BODDY AV
Citation: Sm. Yule et al., CYCLOPHOSPHAMIDE METABOLISM IN CHILDREN WITH FANCONIS-ANEMIA, British Journal of Haematology, 101, 1998, pp. 278-278
PHASE-I STUDY OF TEMOZOLOMIDE IN PEDIATRIC-PATIENTS WITH ADVANCED CANCER
Authors: ESTLIN EJ LASHFORD L ABLETT S PRICE L GOWING R GHOLKAR A KOHLER J LEWIS IJ MORLAND B PINKERTON CR STEVENS R MOTT M STEVENS R NEWELL DR WALKER D DICKSMIREAUX C MCDOWELL H REIDENBERG P STATKEVICH P MARCO A BATRA V DUGAN N PEARSON ADJ
Citation: Ej. Estlin et al., PHASE-I STUDY OF TEMOZOLOMIDE IN PEDIATRIC-PATIENTS WITH ADVANCED CANCER, British Journal of Cancer, 78(5), 1998, pp. 652-661
THYMIDYLATE SYNTHASE EXPRESSION IN NOLATREXED AND METHOTREXATE-RESISTANT HUMAN LEUKEMIA-CELL LINES
Authors: ESTLIN EJ HALL AG LUNEC J NEWELL DR PEARSON ADJ TAYLOR GA
Citation: Ej. Estlin et al., THYMIDYLATE SYNTHASE EXPRESSION IN NOLATREXED AND METHOTREXATE-RESISTANT HUMAN LEUKEMIA-CELL LINES, British Journal of Cancer, 78, 1998, pp. 3-3
GLUTATHIONE LEVELS IN LEUKEMIC BLASTS
Authors: KEARNS P PIETERS R ROTTIER MMA VEERMAN AJP SCHMIEGOLOW K PEARSON ADJ HALL AG
Citation: P. Kearns et al., GLUTATHIONE LEVELS IN LEUKEMIC BLASTS, British Journal of Cancer, 78, 1998, pp. 4-4
DOES TP53 FUNCTION IN NEUROBLASTOMA
Authors: TWEDDLE DA PEARSON ADJ MALCOLM AJ LUNEC J
Citation: Da. Tweddle et al., DOES TP53 FUNCTION IN NEUROBLASTOMA, British Journal of Cancer, 78, 1998, pp. 16-16
VALIDATION OF PHARMACOLOGICALLY-GUIDED DOSING OF CARBOPLATIN IN PEDIATRIC-PATIENTS
Authors: THOMAS HD BODDY AV PEARSON ADJ PINKERTON CR LEWIS I STEVENS M IMESON J HOBSON R NEWELL DR
Citation: Hd. Thomas et al., VALIDATION OF PHARMACOLOGICALLY-GUIDED DOSING OF CARBOPLATIN IN PEDIATRIC-PATIENTS, British Journal of Cancer, 78, 1998, pp. 22-22
BCL2 FAMILY PROTEIN EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: HOGARTH L PEARSON ADJ HALL A
Citation: L. Hogarth et al., BCL2 FAMILY PROTEIN EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Cancer, 78, 1998, pp. 24-24
TP53 AND RELATED PROTEIN EXPRESSION IN PRIMARY AND METASTATIC NEUROBLASTOMA
Authors: TWEDDLE DA MALCOLM AJ REID MM COLE M LUNEC J PEARSON ADJ
Citation: Da. Tweddle et al., TP53 AND RELATED PROTEIN EXPRESSION IN PRIMARY AND METASTATIC NEUROBLASTOMA, British Journal of Cancer, 78, 1998, pp. 68-68
EXPRESSION OF P53, WAF-1, BCL-2, AND BAX IN CENTRAL PRIMITIVE NEUROECTODERMAL TUMORS (CPNET)
Authors: BURNS ASYW JAROS E PEARSON ADJ PERRY RH LUNEC J
Citation: Asyw. Burns et al., EXPRESSION OF P53, WAF-1, BCL-2, AND BAX IN CENTRAL PRIMITIVE NEUROECTODERMAL TUMORS (CPNET), British Journal of Cancer, 78, 1998, pp. 160-160
A STUDY OF THE FEASIBILITY AND ACCURACY OF PHARMACOKINETICALLY GUIDEDETOPOSIDE DOSING IN CHILDREN
Authors: LOWIS SP PRICE L PEARSON ADJ NEWELL DR COLE M
Citation: Sp. Lowis et al., A STUDY OF THE FEASIBILITY AND ACCURACY OF PHARMACOKINETICALLY GUIDEDETOPOSIDE DOSING IN CHILDREN, British Journal of Cancer, 77(12), 1998, pp. 2318-2323
CISPLATIN DOSE-RATE AS A RISK FACTOR FOR NEPHROTOXICITY IN CHILDREN
Authors: SKINNER R PEARSON ADJ ENGLISH MW PRICE L WYLLIE RA COULTHARD MG CRAFT AW
Citation: R. Skinner et al., CISPLATIN DOSE-RATE AS A RISK FACTOR FOR NEPHROTOXICITY IN CHILDREN, British Journal of Cancer, 77(10), 1998, pp. 1677-1682
APOPTOSIS OF N-TYPE NEUROBLASTOMA-CELLS AFTER DIFFERENTIATION WITH 9-CIS-RETINOIC ACID AND SUBSEQUENT WASHOUT
Authors: LOVAT PE IRVING H ANNICCHIARICOPETRUZZELLI M BERNASSOLA F MALCOLM AJ PEARSON ADJ MELINO G REDFERN CPF
Citation: Pe. Lovat et al., APOPTOSIS OF N-TYPE NEUROBLASTOMA-CELLS AFTER DIFFERENTIATION WITH 9-CIS-RETINOIC ACID AND SUBSEQUENT WASHOUT, Journal of the National Cancer Institute, 89(6), 1997, pp. 446-452
CYCLOPHOSPHAMIDE AND IFOSFAMIDE METABOLITES IN THE CEREBROSPINAL-FLUID OF CHILDREN
Authors: YULE SM PRICE L PEARSON ADJ BODDY AV
Citation: Sm. Yule et al., CYCLOPHOSPHAMIDE AND IFOSFAMIDE METABOLITES IN THE CEREBROSPINAL-FLUID OF CHILDREN, Clinical cancer research, 3(11), 1997, pp. 1985-1992
PROMISCUOUS TRANSLOCATIONS OF CHROMOSOME ARM 17Q IN HUMAN NEUROBLASTOMAS
Authors: LASTOWSKA M ROBERTS P PEARSON ADJ LEWIS I WOLSTENHOLME J BOWN N
Citation: M. Lastowska et al., PROMISCUOUS TRANSLOCATIONS OF CHROMOSOME ARM 17Q IN HUMAN NEUROBLASTOMAS, Genes, chromosomes & cancer, 19(3), 1997, pp. 143-149
MITOTIC PERCENTAGE INDEX - A NEW PROGNOSTIC FACTOR FOR CHILDHOOD MEDULLOBLASTOMA
Authors: GILBERTSON RJ JAROS E PERRY RH KELLY PJ LUNEC J PEARSON ADJ
Citation: Rj. Gilbertson et al., MITOTIC PERCENTAGE INDEX - A NEW PROGNOSTIC FACTOR FOR CHILDHOOD MEDULLOBLASTOMA, European journal of cancer, 33(4), 1997, pp. 609-615
ADVANCES IN NEUROBLASTOMA RESEARCH - 1996 - FOREWORD
Authors: BRODEUR GM PEARSON ADJ
Citation: Gm. Brodeur et Adj. Pearson, ADVANCES IN NEUROBLASTOMA RESEARCH - 1996 - FOREWORD, European journal of cancer, 33(12), 1997, pp. 1909-1910
ANALYSIS OF CANDIDATE GENE COAMPLIFICATION WITH MYCN IN NEUROBLASTOMA
Authors: GEORGE RE KENYON R MCGUCKIN AG KOHL N KOGNER P CHRISTIANSEN H PEARSON ADJ LUNEC J
Citation: Re. George et al., ANALYSIS OF CANDIDATE GENE COAMPLIFICATION WITH MYCN IN NEUROBLASTOMA, European journal of cancer, 33(12), 1997, pp. 2037-2042
RETINOIDS IN NEUROBLASTOMA THERAPY - DISTINCT BIOLOGICAL PROPERTIES OF 9-CIS-RETINOIC AND ALL-TRANS-RETINOIC ACID
Authors: LOVAT PE IRVING H ANNICCHIARICOPETRUZZELLI M BERNASSOLA F MALCOLM AJ PEARSON ADJ MELINO G REDFERN CPF
Citation: Pe. Lovat et al., RETINOIDS IN NEUROBLASTOMA THERAPY - DISTINCT BIOLOGICAL PROPERTIES OF 9-CIS-RETINOIC AND ALL-TRANS-RETINOIC ACID, European journal of cancer, 33(12), 1997, pp. 2075-2080
Risultati: 1-25 | 26-50 | 51-75 | 76-90